Sentinel node biopsy in breast cancer

Onkologie

Volumn 23, Issue 2, 2000, Pages 121-126

  Kühn, Thorsten ^a   Santjohanser, C ^a   Koretz, K ^b   Kreienberg, R ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b NONE

Author keywords

Axillary dissection; Breast cancer; Sentinel node biopsy

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; HEALTH CARE QUALITY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; MINIMALLY INVASIVE SURGERY; PATIENT SELECTION; PROGNOSIS; REVIEW; SURGEON; SURGICAL TECHNIQUE;

EID: 0342804458     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000027083     Document Type: Review

References (66)

1. Scholl S, Bieche I, Pallud C, Champeme MH, Beuvon F, Hacene K, Gullick W, Pouillart P, Lidereau R: Relevance of multiple biological parameters in breast cancer prognosis. Breast 1996;5:21-30.
2. Moffat FL, Jr., Senofsky GM, Davis K, Clark KC, Robinson DS, Ketcham AS: Axillary node dissection for early breast cancer: Some is good, but all is better. J Surg Oncol 1992;51:8-13.
3. Moore MP, Kinne DW: Is axillary lymph node dissection necessary in the routine management of breast cancer? Yes. Important Adv Oncol 1996: 245-250.
4. Schildberg FW, Lohe F: Grundlagen und Wert der Lymphadenektomie beim Mammacarcinom. Chirurg 1996;67:771-778.
5. Mathiesen O, Carl J, Bonderup O, Panduro J: Axillary sampling and the risk of erroneous staging of breast cancer. An analysis of 960 consecutive patients. Acta Oncol 1990;29:721-725.
6. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674-681.
7. Chontos AJ, Maher DP, Ratzer ER, Fenoglio ME: Axillary lymph node dissection: Is it required in T1a breast cancer? J Am Coll Surg 1997;184:493-498.
8. Fentiman IS, Mansel RE: The axilla: Not a no-go zone. Lancet 1991;337:221-223.
9. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer 1994;73:664-667.
10. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D: Arm morbidity following treatment of breast cancer with total axillary dissection: A multivariated approach. Oncology 1993;50:445-449.
11. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B: Long-term quality of life after breast cancer: Comparison of 8-year survivors with population controls. J Clin Oncol 1998;16:487-494.
12. Tate JJT, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I: Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1998;15:271-276.
13. De Freitas R, Costa V, Schneider RV, Nicolau MA, Mrussi E: Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1991; 17:240-244.
14. Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-fluorine-18-fluoro-2-deoxy-D-glucose. J Nat Cancer Inst 1996; 88:1204-1209.
15. Suzanne F, Emering C, Wattiez A, Bournazeau JA, Bruhat MA, Jaquetin B: Axillary lymphadenectomy by lipo-aspiration and endoscopic picking. A propos of 72 cases. Chirurgie 1997;122:138-142.
16. Kühn T, Santjohanser C, Koretz K, Böhm W, Kreienberg R: Die endoskopisch axilläre Lymphonodektomie - Ergebnisse einer Pilotstudie. Zentralbl Gynakol 1999;121:82-87.
17. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977;39:456-466.
18. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
19. Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S: Gammaprobe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-1770.
20. Giuliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-398.
21. Krag DN, Weaver DL, Alex JC, Fairbank JT: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-339.
22. Hirsch JI, Tisnado J, Cho SR, Beachley MC: Use of isosulfan blue for identification of lymphatic vessels: experimental and clinical evaluation. Am J Roentgenol 1982;139:1061-1064.
23. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Herman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276: 1818-1822.
24. O'Hea BJ, Hill AD, El Shirbiny AM, Yeh SD, Rosen PP, Coit DG, Borgen PI, Cody HS: Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-427.
25. Diest PJ van, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJLM: Pathological investigations of sentinel lymph nodes. Eur J Nucl Med 1999;26:43-49.
26. Mori M, Mimori K, Inoue H, Barbard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T: Detection of cancer micrometastases in lymph nodes by reserve transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417-3420.
27. Hoon DSB, Sarantou T, Doi F, Chi DDJ, Kuo C, Conrad AJ, Schmid P, Turner R, Giuliano A: Detection of metastatic breast cancer by b-hcg polymerase chain reaction. Int J Cancer 1996;69:369-374.
28. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, Costa A, de Cicco C, Geraghty JG, Luini A, Sacchini V, Veronesi P: Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes, Lancet 1997;349:1864-1867.
29. Diest PJ van, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, Meijer S: Reliability of intra-operative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999;35:14-18.
30. Veronesi U, Zurrida S, Galimberti V: Consequences of sentinel lymph node in clinical decisionmaking in breast cancer and prospects for future studies. Eur J Surg Oncol 1998;24:93-95.
31. Richter T, Nährig J, Komminoth P, Kowolik J, Werner M: Protocol of ultra-rapid immunostaining of frozen sections. J Clin Pathol 1999 (in press).
32. Viale G, Bosari S, Mazzaroi G, Galimberti V, Luini A, Veronesi P, Paganelli G, Bedoni M, Orvieto E: Intraoperalive examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 1999;85:2433-2438.
33. Guenther JM, Krishnamoorthy M, Tan LR: Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3: 336-340.
34. Flett MM, Going JJ, Stanton PD, Cooke TG: Sentinel node localization with breast cancer. 1998;85:991-993.
35. Kühn T, Santjohanser C, Koretz K, Böhm W, Kreienberg R: Die Sentinel-Node-Biopsie nach farbstoffinduzierter Lymphographie. Geburtsh Frauenheilk 1999;59:142-149.
36. Roumen RMH, Valkenburg JGM, Geuskens LM: Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997;23:495-502.
37. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S: Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-283.
38. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS: Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227:645-653.
39. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg S, Shriver C, Felman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer. A multicenter validation study. New Eng J Med 1998;339:941-946.
40. McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJ: Sentinel lymph node biopsy for breast cancer - not yet the standard of care. New Eng J Med 1998;339:990-995.
41. Giuliano AE, Jones RC, Brennan M, Statman R: Sentinel lymphodenectomy in breast cancer. J Clin Oncol 1997;15:2345-2350.
42. Lacour J, Le MG, Hill C, Kramar A, Contesso G, Sarrazin D: Is it useful to remove internal mammary nodes in operable breast cancer? Eur J Surg Oncol 1987;13:309-314.
43. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, Kjaer M, Gadeberg CC, Mouridsen HT, Jensen MB, Zedeler K: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-955.
44. Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, Wilson KS, Knowling MA, Coppin CM, Paradis M, Coldman AJ, Olivotto IA: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-962.
45. Shetty MR, Reiman HM, Jr: Tumor size and axillary metastasis, a correlative occurrence in 1244 cases of breast cancer between 1980 and 1995. Eur J Surg Oncol 1997;23:139-141.
46. Friedman S, Bertin F, Mouriesse H, Benchabat A, Genin J, Sarrazin D, Contesso G: Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. Acta Oncol 1988;27: 483-487.
47. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet 1990; 335:1565-1568.
48. De Mascarel I, Bonichon F, Coindre JM, Trojani M: Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: Reevaluation with longer follow-up. Br J Cancer 1992;66:523-527.
49. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG: Occult axillary node metastases in breast cancer: Their detection and prognostic significance. Br J Cancer 1996;73:88-95.
50. Dowlatshahi K, Fan M, Snider HC, Habib FA: Lymph node micrometastases from breast carcinoma: Reviewing the dilemma. Cancer 1997;80: 1188-1197.
51. Huvos AG, Hutter RV, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971;173:44-46.
52. Fisher ER, Sass R, Fisher B: Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors. Cancer 1987;59: 1554-1559.
53. Borgstein PJ, Meijer S, Pijpers R: Intradermal blue dye to identify sentinel lymph-node in breast cancer. Lancet 1997;349:1668-1669.
54. De Cicco C, Cremonesi M, Luini A, Bartolomei M, Grana C, Prisco G, Galimberti V, Calza P, Viale G, Veronesi U, Paganelli G: Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med 1998;39:2080-2084.
55. De Cicco C, Cremonesi M, Chinol M, Bartolomei M, Pizzamiglio M, Leonardi L, Fiorenza M, Paganelli G: Optimization of axillary lymphoscintigraphy to detect the sentinel node in breast cancer. Tumori 1997;83:539-541.
56. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EF, Boom RP, van Diest PJ, Teule GJ: Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38: 366-368.
57. Veronesi U, Valagussa P: Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981;47:170-175.
58. Hultborn KA, Larsson LG, Ragnhult I: The lymph drainage from the breast to the axillary and parasternal lymph nodes, studied with the aid of colloid198Au. Acta Radiol 1955;43:52-64.
59. Turner-Warwick RT: The lymphatics of the breast. Br J Surg 1959;36:1775-1180.
60. Uren RF, Howman Giles RB, Thompson JF, Malouf D, Ramsey Stewart G, Niesche FW, Renwick SB: Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995;36:1775-1780.
61. Tiourina T, Arends B, Huysmans D, Rutten H, Lemaire B, Muller S: Evaluation of surgical gamma probes for radioguided sentinel node localisation. Eur J Nucl Med 1998;25:1224-1231.
62. Cady B, Stone MD, Schuler JG, Thakur R, Wanner MA, Lavin PT: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996;131:301-308.
63. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-187.
64. Pierquin B, Mazeron JJ, Glaubiger D: Conservative treatment of breast cancer in Europe: Report of the Groupe Europeen de Curietherapie. Radiother Oncol 1986;6:187-198.
65. Sarrazin D, Dewar JA, Arriagada R, Benhamou S, Benhamou E, Lasser P, Fontaine F, Travagli JP, Spielmann M, Le Chevalier T: Conservative management of breast cancer. Br J Surg 1986;73: 604-606.
66. Fowble B, Solin LJ, Schultz DJ, Goodman RL: Frequency, sites of relapse, and outcome of regional node failures following conservative surgery and radiation for early breast cancer. Int J Radiat Oncol Biol Phys 1989;17:703-710.